• Je něco špatně v tomto záznamu ?

Air pollution by carcinogenic PAHs and plasma levels of p53 and p21(WAF1) proteins

Rossner P Jr, Binkova B, Milcova A, Solansky I, Zidzik J, Lyubomirova KD, Farmer PB, Sram RJ.

Jazyk angličtina Země Nizozemsko

Perzistentní odkaz   https://www.medvik.cz/link/bmc10001060

We analyzed the effect of exposure to carcinogenic polycyclic aromatic hydrocarbons (c-PAHs) in ambient air on the plasma levels of p53 and p21(WAF1) proteins among city policemen, bus drivers and controls in three European cities: Prague (Czech Republic), Kosice (Slovakia) and Sofia (Bulgaria). p53 and p21(WAF1) proteins are key regulators of the cell cycle and are accepted as universal markers of genotoxic stress and DNA damage. In total 204 exposed subjects (100 smokers, 104 nonsmokers) and 152 controls (54 smokers, 98 nonsmokers) were analyzed. Personal exposure to c-PAHs was evaluated using personal samplers during the working shift. The levels of p53 and p21(WAF1) proteins were assessed by ELISA assay. There were no differences between the levels of either protein between exposed and controls, or smokers and nonsmokers, in any city. However, we observed significant differences in p53 plasma levels in all subjects regardless of the exposure status between the individual cities (median values: 5, 31, 234pg/ml, p<0.001, for Prague, Kosice and Sofia, respectively). The levels correspond to the differences in exposure levels to c-PAHs and benzo[a]pyrene (B[a]P) in the individual cities. A multiple linear regression analysis confirmed that c-PAHs exposure is a variable significantly affecting levels of both proteins in all locations. When all subjects were divided into the group exposed to below-median levels of c-PAHs and the group exposed to above-median levels of c-PAHs we found significantly higher p53, as well as p21(WAF1) levels in the above-median exposure group (p53, 167pg/ml versus 25pg/ml, p<0.001; p21(WAF1), 2690pg/ml versus 2600pg/ml, p<0.05). Among all subjects p53 plasma levels were positively correlated with p21(WAF1) levels, exposure to B[a]P, c-PAHs and levels of total DNA adducts; for p21(WAF1) levels we observed the positive correlation with cotinine, c-PAHs exposure, total and B[a]P-like DNA adduct levels. In conclusion our results suggest that p53 and p21(WAF1) proteins plasma levels may be useful biomarkers of c-PAHs environmental exposure.

000      
00000naa 2200000 a 4500
001      
bmc10001060
003      
CZ-PrNML
005      
20111210154929.0
008      
100118s2007 ne e eng||
009      
AR
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Rössner, Pavel, $d 1971- $7 mzk2003181802
245    10
$a Air pollution by carcinogenic PAHs and plasma levels of p53 and p21(WAF1) proteins / $c Rossner P Jr, Binkova B, Milcova A, Solansky I, Zidzik J, Lyubomirova KD, Farmer PB, Sram RJ.
314    __
$a Laboratory of Genetic Ecotoxicology, Institute of Experimental Medicine, AS CR and Health Institute of Central Bohemia, Prague, Czech Republic. prossner@biomed.cas.cz
520    9_
$a We analyzed the effect of exposure to carcinogenic polycyclic aromatic hydrocarbons (c-PAHs) in ambient air on the plasma levels of p53 and p21(WAF1) proteins among city policemen, bus drivers and controls in three European cities: Prague (Czech Republic), Kosice (Slovakia) and Sofia (Bulgaria). p53 and p21(WAF1) proteins are key regulators of the cell cycle and are accepted as universal markers of genotoxic stress and DNA damage. In total 204 exposed subjects (100 smokers, 104 nonsmokers) and 152 controls (54 smokers, 98 nonsmokers) were analyzed. Personal exposure to c-PAHs was evaluated using personal samplers during the working shift. The levels of p53 and p21(WAF1) proteins were assessed by ELISA assay. There were no differences between the levels of either protein between exposed and controls, or smokers and nonsmokers, in any city. However, we observed significant differences in p53 plasma levels in all subjects regardless of the exposure status between the individual cities (median values: 5, 31, 234pg/ml, p<0.001, for Prague, Kosice and Sofia, respectively). The levels correspond to the differences in exposure levels to c-PAHs and benzo[a]pyrene (B[a]P) in the individual cities. A multiple linear regression analysis confirmed that c-PAHs exposure is a variable significantly affecting levels of both proteins in all locations. When all subjects were divided into the group exposed to below-median levels of c-PAHs and the group exposed to above-median levels of c-PAHs we found significantly higher p53, as well as p21(WAF1) levels in the above-median exposure group (p53, 167pg/ml versus 25pg/ml, p<0.001; p21(WAF1), 2690pg/ml versus 2600pg/ml, p<0.05). Among all subjects p53 plasma levels were positively correlated with p21(WAF1) levels, exposure to B[a]P, c-PAHs and levels of total DNA adducts; for p21(WAF1) levels we observed the positive correlation with cotinine, c-PAHs exposure, total and B[a]P-like DNA adduct levels. In conclusion our results suggest that p53 and p21(WAF1) proteins plasma levels may be useful biomarkers of c-PAHs environmental exposure.
650    _2
$a znečištění ovzduší $7 D000397
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a lidé $7 D006801
650    _2
$a benzopyren $x toxicita $7 D001564
650    _2
$a karcinogeny životního prostředí $x toxicita $7 D002274
650    _2
$a kotinin $x krev $7 D003367
650    _2
$a inhibitor p21 cyklin-dependentní kinasy $x krev $7 D050759
650    _2
$a adukty DNA $x analýza $7 D018736
650    _2
$a lidé středního věku $7 D008875
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a policie $7 D016495
650    _2
$a polycyklické aromatické uhlovodíky $x toxicita $7 D011084
650    _2
$a nádorový supresorový protein p53 $x krev $7 D016159
700    1_
$a Binková, Blanka $7 xx0104124
700    1_
$a Milcová, Alena $7 xx0094798
700    1_
$a Solanský, Ivo $7 xx0094799
700    1_
$a Židzik, Jozef. $7 xx0207828
700    1_
$a Lyubomirova, Karolina D.
700    1_
$a Farmer, Peter B.
700    1_
$a Šrám, Radim J., $d 1939- $7 jk01130963
773    0_
$w MED00010267 $t Mutation research. Fundamental and molecular mechanisms of mutagenesis $g Roč. 620, č. 1-2 (2007), s. 34-40 $x 1386-1964
910    __
$a ABA008 $b B 1575 $y 8
990    __
$a 20100114162108 $b ABA008
991    __
$a 20100518080033 $b ABA008
999    __
$a ok $b bmc $g 704708 $s 567274
BAS    __
$a 3
BMC    __
$a 2007 $b 620 $c 1-2 $d 34-40 $i 1386-1964 $m Mutation research. Fundamental and molecular mechanisms of mutagenesis $x MED00010267
LZP    __
$a 2010-b1/dkme

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...